nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A5—Teniposide—lymphatic system cancer	0.153	0.249	CbGbCtD
Oxycodone—CYP3A7—Vincristine—lymphatic system cancer	0.0984	0.16	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0984	0.16	CbGbCtD
Oxycodone—CYP3A5—Vincristine—lymphatic system cancer	0.0738	0.12	CbGbCtD
Oxycodone—CYP3A4—Cytarabine—lymphatic system cancer	0.0607	0.0987	CbGbCtD
Oxycodone—CYP3A4—Teniposide—lymphatic system cancer	0.0598	0.0972	CbGbCtD
Oxycodone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0418	0.068	CbGbCtD
Oxycodone—CYP3A4—Vincristine—lymphatic system cancer	0.0288	0.0468	CbGbCtD
Oxycodone—Body temperature increased—Fludarabine—lymphatic system cancer	0.000614	0.0016	CcSEcCtD
Oxycodone—Mental disorder—Carmustine—lymphatic system cancer	0.000613	0.00159	CcSEcCtD
Oxycodone—Malnutrition—Carmustine—lymphatic system cancer	0.000609	0.00158	CcSEcCtD
Oxycodone—Cough—Bleomycin—lymphatic system cancer	0.000609	0.00158	CcSEcCtD
Oxycodone—Angiopathy—Vincristine—lymphatic system cancer	0.000606	0.00157	CcSEcCtD
Oxycodone—Diarrhoea—Teniposide—lymphatic system cancer	0.000605	0.00157	CcSEcCtD
Oxycodone—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000602	0.00156	CcSEcCtD
Oxycodone—Chest pain—Bleomycin—lymphatic system cancer	0.000594	0.00154	CcSEcCtD
Oxycodone—Myalgia—Bleomycin—lymphatic system cancer	0.000594	0.00154	CcSEcCtD
Oxycodone—Coma—Methotrexate—lymphatic system cancer	0.00059	0.00153	CcSEcCtD
Oxycodone—Back pain—Carmustine—lymphatic system cancer	0.000589	0.00153	CcSEcCtD
Oxycodone—Discomfort—Bleomycin—lymphatic system cancer	0.000587	0.00153	CcSEcCtD
Oxycodone—Mental disorder—Vincristine—lymphatic system cancer	0.000585	0.00152	CcSEcCtD
Oxycodone—Chills—Mitoxantrone—lymphatic system cancer	0.000584	0.00152	CcSEcCtD
Oxycodone—Urine output increased—Methotrexate—lymphatic system cancer	0.000583	0.00152	CcSEcCtD
Oxycodone—Confusional state—Bleomycin—lymphatic system cancer	0.000574	0.00149	CcSEcCtD
Oxycodone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000572	0.00149	CcSEcCtD
Oxycodone—Tremor—Carmustine—lymphatic system cancer	0.000571	0.00148	CcSEcCtD
Oxycodone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000569	0.00148	CcSEcCtD
Oxycodone—Oedema—Bleomycin—lymphatic system cancer	0.000569	0.00148	CcSEcCtD
Oxycodone—Infection—Bleomycin—lymphatic system cancer	0.000566	0.00147	CcSEcCtD
Oxycodone—Anaemia—Carmustine—lymphatic system cancer	0.000563	0.00146	CcSEcCtD
Oxycodone—Back pain—Vincristine—lymphatic system cancer	0.000562	0.00146	CcSEcCtD
Oxycodone—Vomiting—Teniposide—lymphatic system cancer	0.000562	0.00146	CcSEcCtD
Oxycodone—Sepsis—Methotrexate—lymphatic system cancer	0.00056	0.00146	CcSEcCtD
Oxycodone—Agitation—Carmustine—lymphatic system cancer	0.00056	0.00145	CcSEcCtD
Oxycodone—Asthenia—Fludarabine—lymphatic system cancer	0.000557	0.00145	CcSEcCtD
Oxycodone—Rash—Teniposide—lymphatic system cancer	0.000557	0.00145	CcSEcCtD
Oxycodone—Dermatitis—Teniposide—lymphatic system cancer	0.000557	0.00145	CcSEcCtD
Oxycodone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000554	0.00144	CcSEcCtD
Oxycodone—Headache—Teniposide—lymphatic system cancer	0.000554	0.00144	CcSEcCtD
Oxycodone—Pruritus—Fludarabine—lymphatic system cancer	0.000549	0.00143	CcSEcCtD
Oxycodone—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000549	0.00143	CcSEcCtD
Oxycodone—Back pain—Mitoxantrone—lymphatic system cancer	0.000548	0.00142	CcSEcCtD
Oxycodone—Leukopenia—Carmustine—lymphatic system cancer	0.000545	0.00142	CcSEcCtD
Oxycodone—Anorexia—Bleomycin—lymphatic system cancer	0.000543	0.00141	CcSEcCtD
Oxycodone—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000541	0.00141	CcSEcCtD
Oxycodone—Anaemia—Vincristine—lymphatic system cancer	0.000537	0.0014	CcSEcCtD
Oxycodone—Agitation—Vincristine—lymphatic system cancer	0.000534	0.00139	CcSEcCtD
Oxycodone—Polyuria—Methotrexate—lymphatic system cancer	0.000533	0.00139	CcSEcCtD
Oxycodone—Hypotension—Bleomycin—lymphatic system cancer	0.000532	0.00138	CcSEcCtD
Oxycodone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000531	0.00138	CcSEcCtD
Oxycodone—Convulsion—Carmustine—lymphatic system cancer	0.000528	0.00137	CcSEcCtD
Oxycodone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000525	0.00137	CcSEcCtD
Oxycodone—Nausea—Teniposide—lymphatic system cancer	0.000525	0.00136	CcSEcCtD
Oxycodone—Anaemia—Mitoxantrone—lymphatic system cancer	0.000523	0.00136	CcSEcCtD
Oxycodone—Vertigo—Vincristine—lymphatic system cancer	0.000522	0.00136	CcSEcCtD
Oxycodone—Leukopenia—Vincristine—lymphatic system cancer	0.00052	0.00135	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000519	0.00135	CcSEcCtD
Oxycodone—Myalgia—Carmustine—lymphatic system cancer	0.000518	0.00135	CcSEcCtD
Oxycodone—Chest pain—Carmustine—lymphatic system cancer	0.000518	0.00135	CcSEcCtD
Oxycodone—Anxiety—Carmustine—lymphatic system cancer	0.000517	0.00134	CcSEcCtD
Oxycodone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000511	0.00133	CcSEcCtD
Oxycodone—Malaise—Mitoxantrone—lymphatic system cancer	0.000511	0.00133	CcSEcCtD
Oxycodone—Dyspnoea—Bleomycin—lymphatic system cancer	0.000508	0.00132	CcSEcCtD
Oxycodone—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000507	0.00132	CcSEcCtD
Oxycodone—Convulsion—Vincristine—lymphatic system cancer	0.000504	0.00131	CcSEcCtD
Oxycodone—Confusional state—Carmustine—lymphatic system cancer	0.000501	0.0013	CcSEcCtD
Oxycodone—Oedema—Carmustine—lymphatic system cancer	0.000497	0.00129	CcSEcCtD
Oxycodone—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000496	0.00129	CcSEcCtD
Oxycodone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000495	0.00129	CcSEcCtD
Oxycodone—Myalgia—Vincristine—lymphatic system cancer	0.000495	0.00129	CcSEcCtD
Oxycodone—Cough—Mitoxantrone—lymphatic system cancer	0.000494	0.00128	CcSEcCtD
Oxycodone—Infection—Carmustine—lymphatic system cancer	0.000494	0.00128	CcSEcCtD
Oxycodone—Vomiting—Fludarabine—lymphatic system cancer	0.000494	0.00128	CcSEcCtD
Oxycodone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000491	0.00128	CcSEcCtD
Oxycodone—Rash—Fludarabine—lymphatic system cancer	0.00049	0.00127	CcSEcCtD
Oxycodone—Dermatitis—Fludarabine—lymphatic system cancer	0.000489	0.00127	CcSEcCtD
Oxycodone—Pain—Bleomycin—lymphatic system cancer	0.000487	0.00127	CcSEcCtD
Oxycodone—Headache—Fludarabine—lymphatic system cancer	0.000487	0.00126	CcSEcCtD
Oxycodone—Tachycardia—Carmustine—lymphatic system cancer	0.000485	0.00126	CcSEcCtD
Oxycodone—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000484	0.00126	CcSEcCtD
Oxycodone—Chest pain—Mitoxantrone—lymphatic system cancer	0.000482	0.00125	CcSEcCtD
Oxycodone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000482	0.00125	CcSEcCtD
Oxycodone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000482	0.00125	CcSEcCtD
Oxycodone—Anxiety—Mitoxantrone—lymphatic system cancer	0.00048	0.00125	CcSEcCtD
Oxycodone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000476	0.00124	CcSEcCtD
Oxycodone—Oedema—Vincristine—lymphatic system cancer	0.000474	0.00123	CcSEcCtD
Oxycodone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000474	0.00123	CcSEcCtD
Oxycodone—Anorexia—Carmustine—lymphatic system cancer	0.000474	0.00123	CcSEcCtD
Oxycodone—Infection—Vincristine—lymphatic system cancer	0.000471	0.00123	CcSEcCtD
Oxycodone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000469	0.00122	CcSEcCtD
Oxycodone—Confusional state—Mitoxantrone—lymphatic system cancer	0.000466	0.00121	CcSEcCtD
Oxycodone—Nervous system disorder—Vincristine—lymphatic system cancer	0.000465	0.00121	CcSEcCtD
Oxycodone—Hypotension—Carmustine—lymphatic system cancer	0.000464	0.00121	CcSEcCtD
Oxycodone—Oedema—Mitoxantrone—lymphatic system cancer	0.000462	0.0012	CcSEcCtD
Oxycodone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000462	0.0012	CcSEcCtD
Oxycodone—Nausea—Fludarabine—lymphatic system cancer	0.000461	0.0012	CcSEcCtD
Oxycodone—Infection—Mitoxantrone—lymphatic system cancer	0.000459	0.00119	CcSEcCtD
Oxycodone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000459	0.00119	CcSEcCtD
Oxycodone—Shock—Mitoxantrone—lymphatic system cancer	0.000455	0.00118	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000453	0.00118	CcSEcCtD
Oxycodone—Urticaria—Bleomycin—lymphatic system cancer	0.000452	0.00118	CcSEcCtD
Oxycodone—Anorexia—Vincristine—lymphatic system cancer	0.000452	0.00118	CcSEcCtD
Oxycodone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000451	0.00117	CcSEcCtD
Oxycodone—Body temperature increased—Bleomycin—lymphatic system cancer	0.00045	0.00117	CcSEcCtD
Oxycodone—Insomnia—Carmustine—lymphatic system cancer	0.00045	0.00117	CcSEcCtD
Oxycodone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000449	0.00117	CcSEcCtD
Oxycodone—Irritability—Methotrexate—lymphatic system cancer	0.000447	0.00116	CcSEcCtD
Oxycodone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000447	0.00116	CcSEcCtD
Oxycodone—Paraesthesia—Carmustine—lymphatic system cancer	0.000446	0.00116	CcSEcCtD
Oxycodone—Mood swings—Methotrexate—lymphatic system cancer	0.000444	0.00115	CcSEcCtD
Oxycodone—Hypotension—Vincristine—lymphatic system cancer	0.000443	0.00115	CcSEcCtD
Oxycodone—Dyspnoea—Carmustine—lymphatic system cancer	0.000443	0.00115	CcSEcCtD
Oxycodone—Somnolence—Carmustine—lymphatic system cancer	0.000442	0.00115	CcSEcCtD
Oxycodone—Anorexia—Mitoxantrone—lymphatic system cancer	0.00044	0.00114	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000432	0.00112	CcSEcCtD
Oxycodone—Decreased appetite—Carmustine—lymphatic system cancer	0.000432	0.00112	CcSEcCtD
Oxycodone—Hypotension—Mitoxantrone—lymphatic system cancer	0.000432	0.00112	CcSEcCtD
Oxycodone—Insomnia—Vincristine—lymphatic system cancer	0.000429	0.00112	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000429	0.00112	CcSEcCtD
Oxycodone—Paraesthesia—Vincristine—lymphatic system cancer	0.000426	0.00111	CcSEcCtD
Oxycodone—Pain—Carmustine—lymphatic system cancer	0.000425	0.0011	CcSEcCtD
Oxycodone—Constipation—Carmustine—lymphatic system cancer	0.000425	0.0011	CcSEcCtD
Oxycodone—Breast disorder—Methotrexate—lymphatic system cancer	0.000423	0.0011	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000421	0.00109	CcSEcCtD
Oxycodone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00042	0.00109	CcSEcCtD
Oxycodone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000415	0.00108	CcSEcCtD
Oxycodone—Decreased appetite—Vincristine—lymphatic system cancer	0.000412	0.00107	CcSEcCtD
Oxycodone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000412	0.00107	CcSEcCtD
Oxycodone—Somnolence—Mitoxantrone—lymphatic system cancer	0.000411	0.00107	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00041	0.00106	CcSEcCtD
Oxycodone—Feeling abnormal—Carmustine—lymphatic system cancer	0.00041	0.00106	CcSEcCtD
Oxycodone—Fatigue—Vincristine—lymphatic system cancer	0.000409	0.00106	CcSEcCtD
Oxycodone—Asthenia—Bleomycin—lymphatic system cancer	0.000409	0.00106	CcSEcCtD
Oxycodone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000407	0.00106	CcSEcCtD
Oxycodone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000406	0.00106	CcSEcCtD
Oxycodone—Pain—Vincristine—lymphatic system cancer	0.000406	0.00105	CcSEcCtD
Oxycodone—Constipation—Vincristine—lymphatic system cancer	0.000406	0.00105	CcSEcCtD
Oxycodone—Asthma—Methotrexate—lymphatic system cancer	0.000405	0.00105	CcSEcCtD
Oxycodone—Pruritus—Bleomycin—lymphatic system cancer	0.000403	0.00105	CcSEcCtD
Oxycodone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000402	0.00104	CcSEcCtD
Oxycodone—Fatigue—Mitoxantrone—lymphatic system cancer	0.000398	0.00104	CcSEcCtD
Oxycodone—Pain—Mitoxantrone—lymphatic system cancer	0.000395	0.00103	CcSEcCtD
Oxycodone—Constipation—Mitoxantrone—lymphatic system cancer	0.000395	0.00103	CcSEcCtD
Oxycodone—Abdominal pain—Carmustine—lymphatic system cancer	0.000393	0.00102	CcSEcCtD
Oxycodone—Body temperature increased—Carmustine—lymphatic system cancer	0.000393	0.00102	CcSEcCtD
Oxycodone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000388	0.00101	CcSEcCtD
Oxycodone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000381	0.00099	CcSEcCtD
Oxycodone—Dysuria—Methotrexate—lymphatic system cancer	0.000379	0.000984	CcSEcCtD
Oxycodone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000378	0.000982	CcSEcCtD
Oxycodone—Abdominal pain—Vincristine—lymphatic system cancer	0.000375	0.000975	CcSEcCtD
Oxycodone—Body temperature increased—Vincristine—lymphatic system cancer	0.000375	0.000975	CcSEcCtD
Oxycodone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000373	0.000969	CcSEcCtD
Oxycodone—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00037	0.000961	CcSEcCtD
Oxycodone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000367	0.000954	CcSEcCtD
Oxycodone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000366	0.000952	CcSEcCtD
Oxycodone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000365	0.000949	CcSEcCtD
Oxycodone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000365	0.000949	CcSEcCtD
Oxycodone—Pneumonia—Methotrexate—lymphatic system cancer	0.000363	0.000944	CcSEcCtD
Oxycodone—Vomiting—Bleomycin—lymphatic system cancer	0.000362	0.000941	CcSEcCtD
Oxycodone—Infestation—Methotrexate—lymphatic system cancer	0.000361	0.000938	CcSEcCtD
Oxycodone—Drowsiness—Methotrexate—lymphatic system cancer	0.000361	0.000938	CcSEcCtD
Oxycodone—Infestation NOS—Methotrexate—lymphatic system cancer	0.000361	0.000938	CcSEcCtD
Oxycodone—Rash—Bleomycin—lymphatic system cancer	0.000359	0.000933	CcSEcCtD
Oxycodone—Dermatitis—Bleomycin—lymphatic system cancer	0.000359	0.000932	CcSEcCtD
Oxycodone—Asthenia—Carmustine—lymphatic system cancer	0.000357	0.000927	CcSEcCtD
Oxycodone—Stomatitis—Methotrexate—lymphatic system cancer	0.000352	0.000915	CcSEcCtD
Oxycodone—Hypersensitivity—Vincristine—lymphatic system cancer	0.00035	0.000909	CcSEcCtD
Oxycodone—Sweating—Methotrexate—lymphatic system cancer	0.000346	0.000899	CcSEcCtD
Oxycodone—Haematuria—Methotrexate—lymphatic system cancer	0.000344	0.000895	CcSEcCtD
Oxycodone—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000341	0.000887	CcSEcCtD
Oxycodone—Epistaxis—Methotrexate—lymphatic system cancer	0.00034	0.000885	CcSEcCtD
Oxycodone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00034	0.000885	CcSEcCtD
Oxycodone—Asthenia—Vincristine—lymphatic system cancer	0.00034	0.000885	CcSEcCtD
Oxycodone—Diarrhoea—Carmustine—lymphatic system cancer	0.00034	0.000884	CcSEcCtD
Oxycodone—Nausea—Bleomycin—lymphatic system cancer	0.000338	0.000879	CcSEcCtD
Oxycodone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000332	0.000862	CcSEcCtD
Oxycodone—Dizziness—Carmustine—lymphatic system cancer	0.000329	0.000854	CcSEcCtD
Oxycodone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000326	0.000847	CcSEcCtD
Oxycodone—Diarrhoea—Vincristine—lymphatic system cancer	0.000325	0.000844	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—lymphatic system cancer	0.000324	0.000842	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000324	0.000842	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—lymphatic system cancer	0.000322	0.000836	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00032	0.000832	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—lymphatic system cancer	0.000318	0.000826	CcSEcCtD
Oxycodone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000316	0.000822	CcSEcCtD
Oxycodone—Vomiting—Carmustine—lymphatic system cancer	0.000316	0.000821	CcSEcCtD
Oxycodone—Dizziness—Vincristine—lymphatic system cancer	0.000314	0.000816	CcSEcCtD
Oxycodone—Rash—Carmustine—lymphatic system cancer	0.000313	0.000815	CcSEcCtD
Oxycodone—Dermatitis—Carmustine—lymphatic system cancer	0.000313	0.000814	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—lymphatic system cancer	0.000312	0.000812	CcSEcCtD
Oxycodone—Headache—Carmustine—lymphatic system cancer	0.000311	0.000809	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—lymphatic system cancer	0.000303	0.000787	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—lymphatic system cancer	0.000302	0.000785	CcSEcCtD
Oxycodone—Vomiting—Vincristine—lymphatic system cancer	0.000302	0.000784	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000301	0.000782	CcSEcCtD
Oxycodone—Rash—Vincristine—lymphatic system cancer	0.000299	0.000778	CcSEcCtD
Oxycodone—Dermatitis—Vincristine—lymphatic system cancer	0.000299	0.000777	CcSEcCtD
Oxycodone—Headache—Vincristine—lymphatic system cancer	0.000297	0.000773	CcSEcCtD
Oxycodone—Nausea—Carmustine—lymphatic system cancer	0.000295	0.000767	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—lymphatic system cancer	0.000294	0.000764	CcSEcCtD
Oxycodone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000294	0.000764	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—lymphatic system cancer	0.000293	0.000761	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000292	0.000759	CcSEcCtD
Oxycodone—Rash—Mitoxantrone—lymphatic system cancer	0.000291	0.000757	CcSEcCtD
Oxycodone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000291	0.000757	CcSEcCtD
Oxycodone—Chills—Methotrexate—lymphatic system cancer	0.000291	0.000756	CcSEcCtD
Oxycodone—Headache—Mitoxantrone—lymphatic system cancer	0.000289	0.000752	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—lymphatic system cancer	0.000284	0.000738	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—lymphatic system cancer	0.000282	0.000733	CcSEcCtD
Oxycodone—Nausea—Vincristine—lymphatic system cancer	0.000282	0.000733	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000276	0.000718	CcSEcCtD
Oxycodone—Nausea—Mitoxantrone—lymphatic system cancer	0.000274	0.000713	CcSEcCtD
Oxycodone—Back pain—Methotrexate—lymphatic system cancer	0.000273	0.000709	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000262	0.00068	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—lymphatic system cancer	0.000261	0.000678	CcSEcCtD
Oxycodone—Malaise—Methotrexate—lymphatic system cancer	0.000254	0.000661	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—lymphatic system cancer	0.000253	0.000659	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—lymphatic system cancer	0.000252	0.000656	CcSEcCtD
Oxycodone—Cough—Methotrexate—lymphatic system cancer	0.000246	0.00064	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—lymphatic system cancer	0.000244	0.000635	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—lymphatic system cancer	0.00024	0.000624	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—lymphatic system cancer	0.00024	0.000624	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—lymphatic system cancer	0.00024	0.000624	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000238	0.00062	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—lymphatic system cancer	0.000237	0.000617	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—lymphatic system cancer	0.000232	0.000603	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00023	0.000598	CcSEcCtD
Oxycodone—Infection—Methotrexate—lymphatic system cancer	0.000229	0.000594	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000226	0.000587	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—lymphatic system cancer	0.000224	0.000581	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000223	0.000578	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—lymphatic system cancer	0.000219	0.00057	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—lymphatic system cancer	0.000215	0.000559	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00021	0.000545	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—lymphatic system cancer	0.000208	0.000541	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000207	0.000537	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000205	0.000534	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—lymphatic system cancer	0.000205	0.000532	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000203	0.000527	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—lymphatic system cancer	0.0002	0.00052	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000199	0.000517	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—lymphatic system cancer	0.000198	0.000516	CcSEcCtD
Oxycodone—Pain—Methotrexate—lymphatic system cancer	0.000197	0.000512	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00019	0.000493	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000188	0.000489	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—lymphatic system cancer	0.000183	0.000475	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000182	0.000473	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000182	0.000473	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00017	0.000441	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—lymphatic system cancer	0.000165	0.000429	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—lymphatic system cancer	0.000163	0.000423	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000158	0.000409	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—lymphatic system cancer	0.000152	0.000396	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—lymphatic system cancer	0.000146	0.00038	CcSEcCtD
Oxycodone—Rash—Methotrexate—lymphatic system cancer	0.000145	0.000377	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—lymphatic system cancer	0.000145	0.000377	CcSEcCtD
Oxycodone—Headache—Methotrexate—lymphatic system cancer	0.000144	0.000375	CcSEcCtD
Oxycodone—Nausea—Methotrexate—lymphatic system cancer	0.000137	0.000355	CcSEcCtD
